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Interventional Cardiology
Pretreatment Platelet Reactivity
Predicts Subsequent Clinical Outcomes in STEMI
While reduced responsiveness to clopidogrel seems to correlate withsubsequent outcomes, there is less data available regarding baseline
platelet reactivity. This substudy of the STRATEGY trial compared platelet
reactivity prior to treatment, after glycoprotein IIb/IIIa inhibitor bolus, and
predischarge with outcomes over the next year. Pretreatment platelet reactivity
was higher in ST-segment elevation myocardial infarction (STEMI) patients
than in control patients, and correlated directly with the peak creatine kinase
measurements and with the risk of TIMI flow grade 3 at the end of the
percutaneous coronary intervention. This increased risk remained throughout
the first year after STEMI. This study suggests that baseline platelet reactivity
can identify those at greatest risk for poor outcomes after STEMI. See page
2178. See figure.
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Myocardial
Infarction and Depression
Understanding Post-MI Depression and Cardiac Risk
Previous studies have suggested an increased risk for cardiac events inpatients with clinical depression after a myocardial infarction (MI). Many
believe that beta-blockers may induce or worsen depression, and this may
hinder their use in post-MI patients. The first study compared the rate for
developing depression among those prescribed or not-prescribed beta-blockers
after an MI. Overall, there was no relationship between beta-blocker use and
the presence of depressive symptoms, though there was a trend towards
increased depression in those with high-dose or long-term beta-blocker usage.
The second study followed nearly 500 post-MI patients for a mean of 2.5 years.
Depression developed in approximately 20% of these patients, half of whom
had a previous history of depression. Compared to non-depressed patients,
those with an incident depression had an increased risk of cardiovascular events
(hazard ratio 1.65), but those without a previous history of depression did not.
See pages 2204, 2209, and 2215. See figure.
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Heart Rhythm Disorders
T-Wave Alternans in Post-MI Patients With Normal EF
Microvolt T-wave alternans (MTWA) has been found to be useful inidentifying low ejection fraction (EF) patients at increased risk of
ventricular arrhythmias. Ikeda and colleagues wanted to extrapolate these
finding for those with preserved EF. Over 1,000 Japanese myocardial infarc-
tion (MI) survivors underwent an MTWA study and were followed for 3 years,
during which time 2% suffered either a fatal or potentially fatal arrhythmia.
The hazard ratio was almost 20 for those who had a positive MTWA. This
study and the accompanying editorial by Klingenheben suggest that MTWA
may be useful in patients with preserved EF in order to identify those patients
most in need of aggressive post-MI therapies. See pages 2268 and 2275.
See figure.
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Cardiac Imaging
Reproducibility of MRI Observations for ARVD
There is debate about the most useful magnetic resonance imaging (MRI) basedcriteria for arrhythmogenic right ventricular dysplasia (ARVD) because many of
these measurements rely on qualitative assessments. Tandri and colleagues studied the
reproducibility and diagnostic accuracy of MRI by comparing the results obtained
from two different MRI readers analyzing the same scans. Overall, there was good
agreement between the readers for all measures except for fat infiltration. This study
suggests that qualitative assessments based onMRI of the right ventricle are reproduc-
ible, but more work is needed before any one criterion can be relied upon for the
diagnosis. See page 2277. See figure.
